Yang Li

Yang Li

Auto-generated profile, based on publicly available information

Yang Li

Department of Chinese Medicine, Jining Traditional Chinese and Western Medicine Hospital, Jining, Shandong, China

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 November 2018 in Biomedical Chromatography
Verified
Journal Article
Closed access
PDF file
YZYa‐Xin Zhao
Ya‐Xin Zhao
MWMeng Wang
Meng Wang
WDWan‐Ting Dong
Wan‐Ting Dong
YLYang Li
Yang Li

29 June 2018 in Experimental and Therapeutic Medicine
Verified
Journal Article
Open access
PDF file
YZYaxin Zhao
Yaxin Zhao
MWMeng Wang
Meng Wang
YLYang Li
Yang Li
WDWanting Dong
Wanting Dong
As a cardiac disease caused by the inflammation of the heart muscle, viral myocarditis (VMC) causes dilated cardiomyopathy, congestive heart failure and even death. With anti‑inflammatory activities, andrographolide has been used in the treatment of various human diseases. In the present study, therapeutic effects of andrographolide on VMC were investigated using a VMC mouse model. Measurement of physiological indexes and echocardiographic examination was performed to explore the effects of andrographolide on cardiac function in mice with VMC. Levels of TNF‑α, hs‑CRP and cTnl in serum were measured by enzyme‑linked immunosorbent assay (ELISA). Effects of andrographolide on the expression of L‑10, STAT3, NF‑κβ p65 and NF‑κβ p50 were investigated by western blot analysis. Results indicated that andrographolide treatment reduced serum levels of TNF‑α, hs‑CRP and cTnl, increased the expression levels of IL‑10 and STAT3 and reduced the expression levels of NF‑κβ p65 and NF‑κβ p50 and the phosphorylation levels of phosphoinositide 3‑kinase (P13K) and AKT in the heart tissues of mice with VMC. In addition, andrographolide also increased the expression level of Iκβα in heart tissue. Therefore, it was concluded that andrographolide may inhibit the progression of VMC by interacting with the IL‑10/STAT3 and NF‑κβ signaling pathways.